Digital PCR Market Size, Share & Industry Analysis, By Product (Systems, Reagents & Consumables), By Industry (Pharmaceuticals / Biotechnology, Diagnostics, Academia, Food & Agriculture, Environmental Science, Others), By Application(Clinical, Non-clinical, Others) Others and Regional Forecast, 2019-2026

Digital PCR (dPCR) is a quantitative PCR method that provides a sensitive and reproducible way of measuring the amount of DNA or RNA present in a sample. Polymerase Chain Reaction expertise is utilized in a variety of applications such as functional investigation of genes, DNA cloning, paternity testing, detection of contagious diseases, diagnosis of hereditary diseases, and forensic sciences. Digital PCR is mainly used to measure cancer genes, distinguish the expression of alleles, and categorize fetal DNA in circulating blood. Growing incidences of contagious diseases coupled with the proven efficacy of dPCR analysis in the diagnosis and estimation of disease-causing microbes, increasing geriatric population, technological advancements in digital PCR are some of the factors that are projected to drive the market growth during the forecast period. According to UNAIDS data, approximately 36.9 million people were suffering from HIV AIDS globally, as of 2017.

Key Market Driver -

Rising prevalence of contagious disease, increasing geriatric population

Key Market Restraint -

High device costs associated with dPCR

Rising prevalence of contagious diseases (HIV, tuberculosis, malaria), growing geriatric population, and increasing awareness among people about digital PCR are some of the factors that are driving the market growth.

However, high device costs associated with digital PCR is likely to hamper the growth of digital PCR market.

Market Segmentation:

By product, the market can be segmented into systems; and reagents & consumables. By industry, the market can be segmented into pharmaceuticals / biotechnology, diagnostics, academia, food & agriculture, environmental science, and others. By application, the market can be segmented into clinical, non-clinical, and others. By clinical, the market is further segmented into oncology, infectious diseases, prenatal screening, organ transplant, and others. By non-clinical segmenat, the market is further segmented into environmental testing, gmo & food testing, and others.

Geographically, the digital PCR market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Players Covered:

The major companies in the global digital PCR market report includes Fluidigm, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Stilla Technologies, RainDance Technologies, JN Medsys, Formulatrix and other prominent players.

Key Insights

• Pricing Analysis by key players


• Technological Developments in Digital PCR


• Key Industry Developments – Mergers & Acquisitions, Partnerships, New Products Introduction

Regional Analysis:

The global digital PCR market is expected to be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global digital PCR market due to an increasing prevalence of contagious disorders (HIV, Hepatitis B) in the U.S. According to the American Association for the Study of Liver Diseases, approximately 7 million Americans had Hepatitis B. Also, the availability of advanced healthcare facilities and research and development in digital PCR are responsible factors for its dominance.

To get information on various segments, share your queries with us

The market in Europe is likely to have substantial market growth throughout the forecast period owing to the rising geriatric population, and rising prevalence of contagious disorders. Asia Pacific and Latin America are expected to register fast market growth during the forecast period due to the increasing number of contagious disorders, and awareness about the digital PCR among the people. On the other hand, the Middle East and Africa is projected to have a lucrative growth in the digital PCR market in the near future.

Segmentation

 Digital PCR Industry Developments

• In November 2019, Bio-Rad Laboratories, Inc. launched QX ONE Droplet Digital PCR System for drug development and manufacturing quality control, as well as highly critical testing environments.


• In October 2019, Bio-Rad Laboratories, Inc. launched dd-Check STEC Solution, first commercially available test for determining the coexistence of the STEC virulence genes, providing rapid and reliable confirmation of the presence of pathogenic STEC


• In February 2019, Stilla Technologies launched high throughput digital PCR chip that will enable its Naica digital PCR system effectively triple its throughput.